Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Visser

Showing results (31-40 of 652) with videos related to

Pageof 66
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|October 25, 2006
[Clinical reasoning and decision-making in practice. A young boy with fever, pancytopenia and an enlarged spleen]L G Visser, J J Verweij
Arthroplasty Today|September 14, 2020
Outcomes of Total Knee Arthroplasty with a Prior Contralateral Above-Knee Amputation: A Report of 10 CasesTimothy G Visser, Mark W Mason
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Bis(tetra-phenyl-arsonium) di-μ-hy-droxido-bis-[(nitrilo-triacetato)-cobalt(III)] octa-hydrateHendrik G Visser, Jack K Clegg
Expert Opinion on Biological Therapy|October 14, 2008
Yellow fever vaccine: past, present and futureAnna H Roukens, Leo G Visser
Nederlands Tijdschrift Voor Geneeskunde|February 28, 2001
[Diagnostic image (8). Intestinal amoebiasis]L G Visser, P C Stuiver
Lancet (London, England)|August 9, 2025
Efficacy and safety of monoclonal antibody PEP for rabiesCorine H GeurtsvanKessel, Leo G Visser
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
2-(Ammonio-meth-yl)pyridinium sulfate monohydrateM Schutte, H G Visser, A Roodt
Inorganic Chemistry|July 26, 2013
Activation of rhenium(I) toward substitution in fac-[Re(N,O'-Bid)(CO)3(HOCH3)] by Schiff-base bidentate ligands (N,O'-Bid)Alice Brink, Hendrik G Visser, Andreas Roodt
Journal of Travel Medicine|April 3, 2019
Fractional-dose yellow fever vaccination: an expert reviewAnna H E Roukens, Leo G Visser
Clinical Pharmacology and Therapeutics|June 27, 2026
Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient"Matthew L Rizk, Sandra A G Visser
Pageof 66

Showing results (31-40 of 652) with videos related to

Sort By:
Pageof 66
Nederlands Tijdschrift Voor Geneeskunde|October 25, 2006
[Clinical reasoning and decision-making in practice. A young boy with fever, pancytopenia and an enlarged spleen]L G Visser, J J Verweij
Arthroplasty Today|September 14, 2020
Outcomes of Total Knee Arthroplasty with a Prior Contralateral Above-Knee Amputation: A Report of 10 CasesTimothy G Visser, Mark W Mason
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Bis(tetra-phenyl-arsonium) di-μ-hy-droxido-bis-[(nitrilo-triacetato)-cobalt(III)] octa-hydrateHendrik G Visser, Jack K Clegg
Expert Opinion on Biological Therapy|October 14, 2008
Yellow fever vaccine: past, present and futureAnna H Roukens, Leo G Visser
Nederlands Tijdschrift Voor Geneeskunde|February 28, 2001
[Diagnostic image (8). Intestinal amoebiasis]L G Visser, P C Stuiver
Lancet (London, England)|August 9, 2025
Efficacy and safety of monoclonal antibody PEP for rabiesCorine H GeurtsvanKessel, Leo G Visser
Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
2-(Ammonio-meth-yl)pyridinium sulfate monohydrateM Schutte, H G Visser, A Roodt
Inorganic Chemistry|July 26, 2013
Activation of rhenium(I) toward substitution in fac-[Re(N,O'-Bid)(CO)3(HOCH3)] by Schiff-base bidentate ligands (N,O'-Bid)Alice Brink, Hendrik G Visser, Andreas Roodt
Journal of Travel Medicine|April 3, 2019
Fractional-dose yellow fever vaccination: an expert reviewAnna H E Roukens, Leo G Visser
Clinical Pharmacology and Therapeutics|June 27, 2026
Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient"Matthew L Rizk, Sandra A G Visser
Pageof 66